AKT1 and central nervous system cancer: Indeed, it has been shown that the PI3K/AKT inhibitor BEZ-235 inhibits DNA damage response proteins, including ATM and DNA-PKcs, in glioma [15], and the PI3K inhibitor LY294002 enhances the efficacy of radiotherapy in cervical cancer [43].